These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35306944)

  • 21. Expanding the relationship context for couple-based HIV prevention: Elucidating women's perspectives on non-traditional sexual partnerships.
    Crankshaw TL; Voce A; Butler LM; Darbes L
    Soc Sci Med; 2016 Oct; 166():169-176. PubMed ID: 27566046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender and Power Dynamics of Social Relationships Shape Willingness to Participate in Biomedical HIV Prevention Research Among South African Adolescents and Young Adults.
    Closson K; Lee L; Dietrich JJ; Beksinska ME; Hornschuh S; Smith P; Smit JA; Ndung'u T; Brockman M; Gray G; Kaida A
    Front Reprod Health; 2021; 3():639391. PubMed ID: 36304054
    [No Abstract]   [Full Text] [Related]  

  • 23. Men's perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study.
    Khoza MN; Delany-Moretlwe S; Scorgie F; Hove J; Selin A; Imrie J; Twine R; Kahn K; Pettifor A; MacPhail C
    PLoS One; 2018; 13(11):e0207654. PubMed ID: 30475851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of male partners in women's participation in research during pregnancy: a case study from the partners demonstration project.
    Ngure K; Trinidad SB; Beima-Sofie K; Baeten JM; Mugo NR; Bukusi EA; Heffron R; John-Stewart G; Kelley MC
    Reprod Health; 2017 Dec; 14(Suppl 3):160. PubMed ID: 29297375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated with Use of Short-Term Pre-Exposure Prophylaxis for HIV Among Female Partners of Migrant Miners in Mozambique.
    Falcao J; Zerbe A; Lahuerta M; Baggaley R; Ahoua L; DiMattei P; Morales F; Ramiro I; El-Sadr WM
    AIDS Patient Care STDS; 2017 Dec; 31(12):528-534. PubMed ID: 29211515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women's sexual scripting in the context of universal access to antiretroviral treatment-findings from the HPTN 071 (PopART) trial in South Africa.
    Viljoen L; Hoddinott G; Malunga S; Vanqa N; Mhlakwaphalwa T; Marthinus A; Mcimeli K; Bond V; Seeley J; Bock P; Hayes R; Reynolds L;
    BMC Womens Health; 2021 Oct; 21(1):370. PubMed ID: 34689783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual Relationship Types, Partner HIV Self-Testing, and Pre-Exposure Prophylaxis Among South African Adolescent Girls and Young Women: A Latent Class Analysis.
    Atkins K; Rucinski K; Mudavanhu M; Holmes L; Mutunga L; Kaufman MR; Bassett J; Van Rie A; Schwartz SR
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):413-421. PubMed ID: 33196552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of boyfriends and intimate sexual partners in the initiation and maintenance of injecting drug use among women in coastal Kenya.
    Mburu G; Limmer M; Holland P
    Addict Behav; 2019 Jun; 93():20-28. PubMed ID: 30682678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E; Tauya T; Reddy K; Mirembe BG; Woeber K; Palanee-Phillips T; Zimba C; Atujuna M; Montgomery ET;
    AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women's perspectives on relationship dynamics with their partners and their role in HIV acquisition, HIV disclosure, hormonal contraceptive uptake, and condom use.
    Chapola JC; Hatfield-Timajchy K; Bula AK; Hurst S; Chinula L; Kourtis AP; Tang JH
    Afr J AIDS Res; 2021 Mar; 20(1):61-69. PubMed ID: 33685375
    [No Abstract]   [Full Text] [Related]  

  • 37. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
    Atujuna M; Newman PA; Wallace M; Eluhu M; Rubincam C; Brown B; Bekker LG
    PLoS One; 2018; 13(2):e0191251. PubMed ID: 29420549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
    Camlin CS; Koss CA; Getahun M; Owino L; Itiakorit H; Akatukwasa C; Maeri I; Bakanoma R; Onyango A; Atwine F; Ayieko J; Kabami J; Mwangwa F; Atukunda M; Owaraganise A; Kwarisiima D; Sang N; Bukusi EA; Kamya MR; Petersen ML; Cohen CR; Charlebois ED; Havlir DV
    AIDS Behav; 2020 Jul; 24(7):2149-2162. PubMed ID: 31955361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.
    Seidman DL; Weber S; Cohan D
    J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21295. PubMed ID: 28361503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.
    Hartmann M; Lanham M; Palanee-Phillips T; Mathebula F; Tolley EE; Peacock D; Pascoe L; Zissette S; Roberts ST; Wagner D; Wilson E; Ayub A; Wilcher R; Montgomery ET;
    AIDS Educ Prev; 2019 Oct; 31(5):433-451. PubMed ID: 31550193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.